DLA Piper Advises Arlington Capital Partners and Everest Clinical Research in Its Acquisition of August Research

NEW YORK--(BUSINESS WIRE)--DLA Piper advised Arlington Capital Partners (ACP) and Everest Clinical Research (Everest), a leading full-service contract research organization (CRO) with expertise in biostatistics and statistical programming, in its acquisition of August Research (August), a European CRO that provides Clinical Trial Services (CTS) and Pharmacovigilance services to a wide variety of pharmaceutical and biotechnology clients. The acquisition of August establishes a European base for